BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 15650784)

  • 1. [Inhibition of hepatitis C virus gene expression by antisense nucleotide in vitro].
    Li YN; Yu M; Wu WQ; Gao JX; Wang H; Ji SP; Wang QH; Si CW
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):341-3. PubMed ID: 15650784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The promoter activity of the DNA sequence corresponding to HCV 5'UTR in HepG2].
    Chen WX; Zhang J; Huang Y; Zhang J; Tang N; Huang AL
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):897-9. PubMed ID: 16381633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of short interfering RNAs on hepatitis C Virus 5' untranslated region expression].
    Chen ZJ; Zhang LH; Li W; Liu X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):319-21. PubMed ID: 18322589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human liver cell line exhibits efficient translation of HCV RNAs produced by a recombinant adenovirus expressing T7 RNA polymerase.
    Aoki Y; Aizaki H; Shimoike T; Tani H; Ishii K; Saito I; Matsuura Y; Miyamura T
    Virology; 1998 Oct; 250(1):140-50. PubMed ID: 9770428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
    Alt M; Renz R; Hofschneider PH; Paumgartner G; Caselmann WH
    Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice.
    Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J
    Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral effects of antisense RNA on hepatitis C virus RNA translation and expression.
    Wakita T; Moradpour D; Tokushihge K; Wands JR
    J Med Virol; 1999 Mar; 57(3):217-22. PubMed ID: 10022790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association with 5'-untranslated region and response to interferon in chronic hepatitis C.
    Katano Y; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Goto H
    Hepatogastroenterology; 2007; 54(75):854-7. PubMed ID: 17591078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational control of apolipoprotein B mRNA: regulation via cis elements in the 5' and 3' untranslated regions.
    Pontrelli L; Sidiropoulos KG; Adeli K
    Biochemistry; 2004 Jun; 43(21):6734-44. PubMed ID: 15157107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter activity of SARS coronavirus 5' UTR sequence in eukaryotic cells.
    Zhang JJ; Huang AL; Shi XL; Zhang XF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):5-9. PubMed ID: 16468630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A somatic mutation in the 5'UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency.
    Signori E; Bagni C; Papa S; Primerano B; Rinaldi M; Amaldi F; Fazio VM
    Oncogene; 2001 Jul; 20(33):4596-600. PubMed ID: 11494157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The construction and evaluation of antisense RNA expression vector targeting at HCV 5'NCR].
    Wang XH; Wang SQ; Guan W; Mao BZ
    Sheng Wu Gong Cheng Xue Bao; 2001 Mar; 17(2):179-82. PubMed ID: 11411227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of different 5' untranslated region hepatitis C virus variants during post-transfusion and post-transplantation infection.
    Gallegos-Orozco JF; Arenas JI; Vargas HE; Kibler KV; Wilkinson JK; Nowicki M; Radkowski M; Nasseri J; Rakela J; Laskus T
    J Viral Hepat; 2006 Jul; 13(7):489-98. PubMed ID: 16792543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem-loop structures II-IV of the 5' untranslated sequences are required for the expression of the full-length hepatitis C virus genome.
    Qi ZT; Kalkeri G; Hanible J; Prabhu R; Bastian F; Garry RF; Dash S
    Arch Virol; 2003 Mar; 148(3):449-67. PubMed ID: 12607098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hepatitis C virus 5' untranslated region gene amplified by rapid amplification of cDNA ends and its secondary structure.
    Qin ZX; Cong X; Jiang D; Ha MH; Chen HS; Wei L
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):368-72. PubMed ID: 14607708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of HIV on genomic variability in the 5'UTR of HCV in Indian patients with HCV/HIV co-infection.
    Chaudhary A; Kukreti H; Pasha ST; Gupta S; Kumari M; Khare S; Lal S; Rai A
    Intervirology; 2008; 51(4):224-9. PubMed ID: 18781077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell-penetrating peptide.
    Wei B; Wei Y; Zhang K; Wang J; Xu R; Zhan S; Lin G; Wang W; Liu M; Wang L; Zhang R; Li J
    Biomed Pharmacother; 2009 May; 63(4):313-8. PubMed ID: 18823738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of hepatitis C virus gene expression by adenoviral vectors encoding antisense RNA in vitro and in vivo.
    González-Carmona MA; Vogt A; Heinicke T; Quasdorff M; Hoffmann P; Yildiz Y; Schneider C; Serwe M; Bartenschlager R; Sauerbruch T; Caselmann WH
    J Hepatol; 2011 Jul; 55(1):19-28. PubMed ID: 21145870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
    Kim M; Shin D; Kim SI; Park M
    Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of HCV IRES controlled reporter gene expression by RNA interference].
    Chen WX; Shan LN; Chen J; Zhang ZZ; Zhang BQ; Huang AL
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):521-4. PubMed ID: 16867275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.